Ke-jin Wu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.

Journal: BMJ (Clinical research ed.)

Published: October 23, 2024

A retrospective clinical study of patients with pregnancy-associated breast cancer among multiple centers in China (CSBrS-008).

A retrospective clinical study of patients with pregnancy-associated breast cancer among multiple centers in China (CSBrS-008).

Journal: Chinese medical journal

Published: September 23, 2021

Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021.

Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021.

Journal: Chinese medical journal

Published: August 30, 2021

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial.

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial.

Journal: The Lancet regional health. Western Pacific

Published: February 07, 2021

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: August 14, 2020

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.

Journal: Cancer

Published: October 22, 2018

The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer

The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 22, 2013

Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells.

Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells.

Journal: Cancer cell international

Published: April 27, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026